Sargent Investment Group, LLC Phasebio Pharmaceuticals Inc C Call Options Transaction History
Sargent Investment Group, LLC
- $546 Million
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|